Benjamin S Chen, MD
Internal Medicine · Oakland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 3
- Since medical school
- 16 years
- University of Missouri, Columbia School of Medicine, 2010
Offices
3 locations · La Clinica De La Raza Inc · Permanente Medical Group Inc
Looking this up.
Hospitals listed: 557194 · 557754 · Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp · Kaiser Foundation Hospital - Oakland/Richmond. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chen’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A121497 · Current
Licensed to practise in California · since 2012 · expires 2027-11-30 · University of Missouri-Columbia School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- Kaiser Foundation Hospital - Oakland/RichmondOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.203, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.334, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Kaiser Foundation Hospital - Oakland/Richmond
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 2 the same, 2 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.203 | Worse | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.334 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0 to 2.01) · 443 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.01 (0.62 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 52 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.2 · 40 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.7 · 94 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.8 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 4,684 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.03 to 0.48) · 2,673 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.33 (0.12 to 0.54) · 2,783 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.39 (0.96 to 5.81) · 381 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.32) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.44 to 3.71) · 359 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.63 (0 to 16.81) · 123 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.35 (1.31 to 9.38) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.04 (0.54 to 3.55) · 115 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.79 (0 to 1.61) · 2,133 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.562 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.715 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.876 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 312 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 974 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 55.2 · 127 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 10 · 112 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20 · 819 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 262 cases | None | Jul 2023 – Jun 2025 |
What patients said (2,982 patients answered, 23% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$1,728
Medicare paid this office $1,728 for 84 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Hemoglobin a1c level | 58 | $380 | $4 |
| Urinalysis, manual test | 12 | $55 | $3 |
Who their Medicare patients are
84 Original Medicare patients in 2024. Average age 71 · Women 48% · Health risk score 1.59. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 75% · Chronic kidney disease 33% · Coronary heart disease 15% · COPD 15%.
The office billed $3,894, Medicare allowed $2,019 and paid $1,728; for 131 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 84 | 131 | 71 | 1.59 | $3,894 | $1,728 |
| 2021 | 13 | 13 | 74 | 2.87 | $2,928 | $1,140 |
| 2019 | 13 | 13 | 66 | 3.73 | $3,112 | $1,057 |
| 2017 | 13 | 13 | 72 | 2.19 | $3,047 | $1,057 |
| 2016 | 28 | 28 | 73 | 4.52 | $6,546 | $1,984 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2016: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $729 | $61 |
Medicaid work
$338,425 in 2024
Medicaid paid $338,425 for 5,219 billed services this clinician did in 2024, up to 119 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,399 | $329,940 |
| Return visit (30+ min) | 1,074 | $3,778 |
| Long return visit (40+ min) | 510 | $1,842 |
| Short return visit (20+ min) | 883 | $1,596 |
| Annual alcohol misuse screening, 5 to 15 minutes | 315 | $693 |
| Short return visit | 234 | $440 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 43 | $87 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 252 | $25 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 115 | $24 |
| Hemoglobin A1C level | 318 | $0 |
| Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use | 49 | $0 |
| Administration of influenza virus vaccine | 27 | $0 |
| 2024 | 5,219 | 12 | 119 | $338,425 |
| 2023 | 4,763 | 11 | 123 | $315,152 |
| 2022 | 3,290 | 9 | 104 | $210,440 |
| 2021 | 3,958 | 8 | 125 | $299,699 |
| 2020 | 3,377 | 8 | 138 | $268,795 |
| 2019 | 2,876 | 9 | 120 | $202,042 |
| 2018 | 2,237 | 7 | 125 | $201,400 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,354 | $307,480 |
| Return visit (30+ min) | 1,117 | $3,013 |
| Long return visit (40+ min) | 467 | $2,029 |
| Short return visit (20+ min) | 804 | $1,475 |
| Annual alcohol misuse screening, 5 to 15 minutes | 332 | $430 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 26 | $310 |
| Short return visit | 119 | $268 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 78 | $113 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 205 | $34 |
| Hemoglobin A1C level | 248 | $0 |
| Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use | 13 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 939 | $208,654 |
| Long return visit (40+ min) | 320 | $572 |
| Return visit (30+ min) | 845 | $516 |
| Short return visit (20+ min) | 643 | $465 |
| Annual alcohol misuse screening, 5 to 15 minutes | 228 | $132 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 66 | $55 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 146 | $24 |
| Short return visit | 65 | $23 |
| Hemoglobin A1C level | 38 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 1,368 | $298,564 |
| Return visit (30+ min) | 1,208 | $686 |
| Short return visit (20+ min) | 940 | $279 |
| Long return visit (40+ min) | 206 | $170 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 110 | $0 |
| Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use | 18 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 76 | $0 |
| Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use | 32 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 1,286 | $267,861 |
| Return visit (30+ min) | 736 | $483 |
| Short return visit (20+ min) | 1,187 | $439 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 16 | $12 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 34 | $0 |
| Hemoglobin A1C level | 27 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 20 | $0 |
| Alcohol and/or drug screening | 71 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 1,059 | $200,365 |
| Short return visit (20+ min) | 821 | $1,124 |
| Return visit (30+ min) | 492 | $530 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 289 | $24 |
| Hemoglobin A1C level | 72 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 37 | $0 |
| Short return visit | 37 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 12 | $0 |
| Alcohol and/or drug screening | 57 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 1,178 | $199,930 |
| Short return visit (20+ min) | 544 | $943 |
| Return visit (30+ min) | 336 | $516 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 113 | $11 |
| Hemoglobin A1C level | 32 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 17 | $0 |
| Alcohol and/or drug screening | 17 | $0 |
Drugs they prescribed that Part D paid
$576,008
Pharmacies billed $576,008 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (108 of 3,769) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
3,127 generic and 588 brand-name prescriptions · $576,008 in drug cost · 46 antibiotic prescriptions to 21 people · 33 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 100 | $144,136 | $1,441 |
| Ozempic | 34 | $59,362 | $1,746 |
| Rybelsus | 22 | $47,543 | $2,161 |
| Eliquis | 34 | $37,814 | $1,112 |
| Vemlidy | 24 | $35,310 | $1,471 |
See all 89 drugs
| Jardiance | 100 | $144,136 | $1,441 |
| Ozempic | 34 | $59,362 | $1,746 |
| Rybelsus | 22 | $47,543 | $2,161 |
| Eliquis | 34 | $37,814 | $1,112 |
| Vemlidy | 24 | $35,310 | $1,471 |
| Myrbetriq | 27 | $21,661 | $802 |
| Basaglar Kwikpen U-100 | 32 | $13,937 | $436 |
| Entresto | 11 | $9,411 | $856 |
| Buprenorphine-Naloxone | 35 | $7,280 | $208 |
| Dulera | 22 | $7,236 | $329 |
| Incruse Ellipta | 20 | $6,323 | $316 |
| Lantus Solostar | 27 | $4,320 | $160 |
| Varenicline | 16 | $4,263 | $266 |
| Gabapentin | 103 | $3,141 | $30 |
| Novolog Flexpen | 15 | $2,907 | $194 |
| Ultra-Fine Short Pen Needle | 20 | $2,247 | $112 |
| Diclofenac | 73 | $1,774 | $24 |
| Duloxetine | 69 | $1,739 | $25 |
| Carbamazepine Er | 13 | $1,644 | $126 |
| Hydrocodone-Acetaminophen | 55 | $1,619 | $29 |
| Atorvastatin | 270 | $1,530 | $6 |
| Rifampin | 12 | $1,522 | $127 |
| Potassium Chloride | 27 | $1,356 | $50 |
| Enalapril Maleate | 58 | $1,154 | $20 |
| Albuterol Sulfate Hfa | 30 | $1,093 | $36 |
| Tamsulosin | 77 | $1,049 | $14 |
| Valsartan | 14 | $1,031 | $74 |
| Famotidine | 54 | $943 | $17 |
| Baclofen | 30 | $918 | $31 |
| Metformin | 156 | $880 | $6 |
| Colchicine | 12 | $849 | $71 |
| Amlodipine Besylate | 201 | $781 | $4 |
| Sumatriptan | 14 | $710 | $51 |
| Omeprazole | 75 | $688 | $9 |
| Alendronate | 69 | $682 | $10 |
| Naloxone | 11 | $676 | $61 |
| Lisinopril | 119 | $609 | $5 |
| Desvenlafaxine Succinate Er | 11 | $603 | $55 |
| Betamethasone Dipropionate | 11 | $545 | $50 |
| Quetiapine | 14 | $521 | $37 |
| Chlorthalidone | 17 | $504 | $30 |
| Diltiazem 24hr Er (Cd) | 14 | $490 | $35 |
| Metoprolol | 36 | $488 | $14 |
| Rosuvastatin | 15 | $486 | $32 |
| Fluticasone Propionate | 67 | $476 | $7 |
| Simvastatin | 67 | $418 | $6 |
| Azelastine | 23 | $396 | $17 |
| Lovastatin | 44 | $393 | $9 |
| Losartan | 49 | $386 | $8 |
| Olanzapine | 12 | $364 | $30 |
| Pregabalin | 19 | $357 | $19 |
| Mirtazapine | 19 | $326 | $17 |
| Pantoprazole | 30 | $323 | $11 |
| Glipizide | 33 | $284 | $9 |
| Carvedilol | 27 | $266 | $10 |
| Triamcinolone Acetonide | 49 | $265 | $5 |
| Lisinopril-Hydrochlorothiazide | 31 | $259 | $8 |
| Finasteride | 20 | $255 | $13 |
| Ondansetron Odt | 24 | $254 | $11 |
| Clotrimazole | 15 | $246 | $16 |
| Divalproex | 15 | $237 | $16 |
| Trazodone | 18 | $236 | $13 |
| Terazosin | 17 | $235 | $14 |
| Olmesartan Medoxomil | 22 | $231 | $10 |
| Ketoconazole | 18 | $228 | $13 |
| Oxycodone-Acetaminophen | 13 | $216 | $17 |
| Hydrocortisone | 22 | $210 | $10 |
| Levothyroxine | 24 | $199 | $8 |
| Losartan-Hydrochlorothiazide | 11 | $188 | $17 |
| Oxycodone | 15 | $180 | $12 |
| Clopidogrel | 18 | $171 | $9 |
| Hydrochlorothiazide | 53 | $159 | $3 |
| Spironolactone | 13 | $159 | $12 |
| Metoprolol | 23 | $157 | $7 |
| Lurasidone | 11 | $143 | $13 |
| Nitrofurantoin Mono-Macro | 11 | $142 | $13 |
| Sertraline | 16 | $121 | $8 |
| Furosemide | 21 | $118 | $6 |
| Loperamide | 13 | $117 | $9 |
| Allopurinol | 20 | $103 | $5 |
| Cyclobenzaprine | 15 | $97 | $6 |
| Ibuprofen | 25 | $95 | $4 |
| Citalopram Hbr | 13 | $95 | $7 |
| Prednisone | 25 | $84 | $3 |
| Amlodipine Besylate-Benazepril | 14 | $78 | $6 |
| Naproxen | 12 | $56 | $5 |
| Meclizine | 15 | $38 | $3 |
| Meloxicam | 18 | $27 | $1 |
| Tramadol | 19 | $23 | $1 |
Year by year
| 2024 | 3,769 | 294 | 3% (108) | 16% | $576,008 |
| 2023 | 3,566 | 277 | 3% (102) | 16% | $644,578 |
| 2022 | 3,937 | 301 | 3% (133) | 17% | $587,286 |
| 2021 | 4,089 | 293 | 4% (165) | 18% | $518,210 |
| 2020 | 3,700 | 263 | 3% (126) | 20% | $430,953 |
| 2019 | 3,548 | 243 | 2% (67) | 20% | $581,992 |
| 2018 | 3,291 | 214 | 2% (60) | 19% | $388,212 |
| 2017 | 3,111 | 198 | 3% (77) | 18% | $403,785 |
| 2016 | 2,345 | 195 | 4% (93) | 17% | $238,796 |
| 2015 | 1,183 | 177 | 7% (83) | 18% | $77,742 |
| 2014 | 284 | 73 | 7% (21) | 18% | $12,784 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 75 drugs
| Jardiance | 55 | $102,573 | $1,865 |
| Ozempic | 35 | $66,913 | $1,912 |
| Trulicity | 20 | $37,958 | $1,898 |
| Eliquis | 27 | $33,830 | $1,253 |
| Rybelsus | 17 | $21,275 | $1,251 |
| Novolog Flexpen | 16 | $20,467 | $1,279 |
| Vemlidy | 13 | $19,924 | $1,533 |
| Lantus Solostar | 16 | $19,922 | $1,245 |
| Myrbetriq | 20 | $18,598 | $930 |
| Basaglar Kwikpen U-100 | 30 | $17,370 | $579 |
| Symbicort | 37 | $17,181 | $464 |
| Spiriva Respimat | 26 | $14,644 | $563 |
| Tradjenta | 12 | $11,098 | $925 |
| Duloxetine | 58 | $8,540 | $147 |
| Atorvastatin | 243 | $7,981 | $33 |
| Incruse Ellipta | 20 | $7,657 | $383 |
| Novolog Mix 70-30 Flexpen | 12 | $7,582 | $632 |
| Flovent Hfa | 18 | $6,321 | $351 |
| Gabapentin | 108 | $5,733 | $53 |
| Tamsulosin | 83 | $4,825 | $58 |
| Amlodipine Besylate | 177 | $4,248 | $24 |
| Metformin | 166 | $3,875 | $23 |
| Carbamazepine Er | 14 | $3,774 | $270 |
| Buprenorphine-Naloxone | 26 | $3,763 | $145 |
| Enalapril Maleate | 49 | $3,412 | $70 |
| Hydrocodone-Acetaminophen | 72 | $3,213 | $45 |
| Diclofenac | 85 | $2,862 | $34 |
| Potassium Chloride | 40 | $2,572 | $64 |
| Lisinopril | 110 | $2,399 | $22 |
| Ventolin Hfa | 37 | $2,306 | $62 |
| Baclofen | 43 | $2,263 | $53 |
| Famotidine | 42 | $1,828 | $44 |
| Omeprazole | 95 | $1,657 | $17 |
| Olanzapine | 12 | $1,590 | $132 |
| Alendronate | 50 | $1,349 | $27 |
| Azelastine | 31 | $1,281 | $41 |
| Olmesartan Medoxomil | 15 | $1,182 | $79 |
| Simvastatin | 56 | $1,179 | $21 |
| Losartan | 58 | $1,165 | $20 |
| Albuterol Sulfate Hfa | 29 | $1,009 | $35 |
| Mirtazapine | 24 | $1,000 | $42 |
| Rosuvastatin | 16 | $953 | $60 |
| Pregabalin | 32 | $944 | $29 |
| Fluticasone Propionate | 57 | $825 | $14 |
| Glipizide | 32 | $762 | $24 |
| Lovastatin | 47 | $740 | $16 |
| Levothyroxine | 40 | $734 | $18 |
| Finasteride | 24 | $688 | $29 |
| Metoprolol | 24 | $688 | $29 |
| Carvedilol | 34 | $672 | $20 |
| Pantoprazole | 43 | $662 | $15 |
| Ondansetron Odt | 18 | $651 | $36 |
| Clonidine | 17 | $572 | $34 |
| Propranolol | 17 | $566 | $33 |
| Lisinopril-Hydrochlorothiazide | 30 | $542 | $18 |
| Topiramate | 12 | $539 | $45 |
| Sertraline | 17 | $500 | $29 |
| Trazodone | 25 | $489 | $20 |
| Clotrimazole | 18 | $488 | $27 |
| Terazosin | 13 | $462 | $36 |
| Clopidogrel | 13 | $424 | $33 |
| Hydrocortisone | 20 | $421 | $21 |
| Quetiapine | 17 | $396 | $23 |
| Allopurinol | 18 | $385 | $21 |
| Triamcinolone Acetonide | 45 | $385 | $9 |
| Metoprolol | 19 | $339 | $18 |
| Cyclobenzaprine | 24 | $325 | $14 |
| Tramadol | 18 | $278 | $15 |
| Ketoconazole | 18 | $277 | $15 |
| Prednisone | 35 | $263 | $8 |
| Ibuprofen | 31 | $234 | $8 |
| Furosemide | 25 | $229 | $9 |
| Hydrochlorothiazide | 47 | $228 | $5 |
| Testosterone Cypionate | 15 | $161 | $11 |
| Naproxen | 11 | $97 | $9 |
2022: 90 drugs
| Jardiance | 62 | $96,644 | $1,559 |
| Novolog Flexpen | 40 | $48,291 | $1,207 |
| Trulicity | 23 | $27,825 | $1,210 |
| Eliquis | 18 | $22,875 | $1,271 |
| Myrbetriq | 24 | $21,720 | $905 |
| Vemlidy | 15 | $21,130 | $1,409 |
| Ozempic | 12 | $20,870 | $1,739 |
| Basaglar Kwikpen U-100 | 42 | $20,220 | $481 |
| Symbicort | 32 | $17,759 | $555 |
| Breo Ellipta | 24 | $11,469 | $478 |
| Tradjenta | 13 | $10,102 | $777 |
| Farxiga | 11 | $10,021 | $911 |
| Buprenorphine-Naloxone | 41 | $8,989 | $219 |
| Spiriva Respimat | 16 | $8,619 | $539 |
| Flovent Hfa | 24 | $7,378 | $307 |
| Novolog Mix 70-30 Flexpen | 11 | $6,581 | $598 |
| Pradaxa | 12 | $6,437 | $536 |
| Lantus | 13 | $6,073 | $467 |
| Duloxetine | 66 | $5,371 | $81 |
| Incruse Ellipta | 14 | $5,360 | $383 |
| Anoro Ellipta | 11 | $5,271 | $479 |
| Atorvastatin | 228 | $5,206 | $23 |
| Gabapentin | 118 | $5,154 | $44 |
| Tenofovir Disoproxil | 12 | $4,991 | $416 |
| Calcipotriene | 14 | $4,033 | $288 |
| Hydrocodone-Acetaminophen | 80 | $3,410 | $43 |
| Carbamazepine Er | 16 | $3,210 | $201 |
| Baclofen | 46 | $2,560 | $56 |
| Amlodipine Besylate | 215 | $2,375 | $11 |
| Enalapril Maleate | 69 | $2,305 | $33 |
| Tamsulosin | 75 | $2,300 | $31 |
| Metformin | 194 | $2,097 | $11 |
| Albuterol Sulfate Hfa | 45 | $1,773 | $39 |
| Diclofenac | 62 | $1,672 | $27 |
| Halobetasol Propionate | 12 | $1,652 | $138 |
| Pregabalin | 43 | $1,608 | $37 |
| Olanzapine | 18 | $1,567 | $87 |
| Betamethasone Dipropionate | 23 | $1,562 | $68 |
| Ventolin Hfa | 24 | $1,466 | $61 |
| Colchicine | 12 | $1,395 | $116 |
| Losartan | 89 | $1,330 | $15 |
| Lisinopril | 120 | $1,259 | $10 |
| Omeprazole | 85 | $1,104 | $13 |
| Bupropion Xl | 13 | $992 | $76 |
| Oxybutynin Chloride Er | 12 | $984 | $82 |
| Famotidine | 40 | $942 | $24 |
| Sertraline | 43 | $938 | $22 |
| Levothyroxine | 40 | $932 | $23 |
| Oxycodone | 18 | $919 | $51 |
| Fluticasone Propionate | 66 | $880 | $13 |
| Lovastatin | 65 | $828 | $13 |
| Quetiapine | 22 | $789 | $36 |
| Glipizide | 48 | $782 | $16 |
| Losartan-Hydrochlorothiazide | 11 | $771 | $70 |
| Terazosin | 12 | $763 | $64 |
| Carvedilol | 39 | $712 | $18 |
| Metoprolol | 24 | $654 | $27 |
| Simvastatin | 79 | $646 | $8 |
| Potassium Chloride | 26 | $643 | $25 |
| Propranolol | 24 | $631 | $26 |
| Allopurinol | 29 | $619 | $21 |
| Finasteride | 30 | $586 | $20 |
| Clobetasol Propionate | 11 | $561 | $51 |
| Warfarin | 13 | $544 | $42 |
| Chlorthalidone | 13 | $529 | $41 |
| Clopidogrel | 16 | $505 | $32 |
| Clonidine | 22 | $491 | $22 |
| Alendronate | 27 | $483 | $18 |
| Pantoprazole | 34 | $364 | $11 |
| Mirtazapine | 23 | $360 | $16 |
| Lisinopril-Hydrochlorothiazide | 25 | $353 | $14 |
| Rosuvastatin | 13 | $306 | $24 |
| Hydrochlorothiazide | 56 | $299 | $5 |
| Ondansetron Odt | 11 | $297 | $27 |
| Ibuprofen | 39 | $278 | $7 |
| Furosemide | 25 | $265 | $11 |
| Metoprolol | 28 | $249 | $9 |
| Donepezil | 12 | $239 | $20 |
| Trazodone | 22 | $191 | $9 |
| Ketoconazole | 14 | $158 | $11 |
| Prednisone | 12 | $155 | $13 |
| Lamotrigine | 15 | $139 | $9 |
| Meclizine | 25 | $139 | $6 |
| Meloxicam | 17 | $129 | $8 |
| Tramadol | 15 | $118 | $8 |
| Sumatriptan | 11 | $116 | $11 |
| Triamcinolone Acetonide | 19 | $116 | $6 |
| Isosorbide Mononitrate Er | 13 | $109 | $8 |
| Naproxen | 20 | $97 | $5 |
| Cyclobenzaprine | 11 | $51 | $5 |
2021: 96 drugs
| Jardiance | 40 | $37,820 | $946 |
| Novolog Flexpen | 40 | $37,614 | $940 |
| Eliquis | 30 | $26,857 | $895 |
| Basaglar Kwikpen U-100 | 49 | $20,613 | $421 |
| Trulicity | 21 | $20,611 | $981 |
| Myrbetriq | 22 | $18,177 | $826 |
| Ozempic | 12 | $17,822 | $1,485 |
| Symbicort | 23 | $14,587 | $634 |
| Lantus | 24 | $13,172 | $549 |
| Tradjenta | 12 | $11,894 | $991 |
| Humalog Kwikpen U-100 | 12 | $10,768 | $897 |
| Lantus Solostar | 22 | $10,405 | $473 |
| Advair Diskus | 18 | $7,968 | $443 |
| Pradaxa | 15 | $7,514 | $501 |
| Flovent Hfa | 30 | $7,460 | $249 |
| Spiriva Respimat | 14 | $6,993 | $499 |
| Breo Ellipta | 18 | $6,990 | $388 |
| Incruse Ellipta | 15 | $5,620 | $375 |
| Chantix | 12 | $5,450 | $454 |
| Atrovent Hfa | 11 | $4,999 | $454 |
| Wixela Inhub | 13 | $4,646 | $357 |
| Carbamazepine Er | 19 | $4,568 | $240 |
| Gabapentin | 113 | $4,361 | $39 |
| Buprenorphine-Naloxone | 17 | $3,978 | $234 |
| Atorvastatin | 260 | $3,761 | $14 |
| Hydrocodone-Acetaminophen | 95 | $3,592 | $38 |
| Albuterol Sulfate Hfa | 52 | $2,316 | $45 |
| Tamsulosin | 82 | $2,191 | $27 |
| Ultra-Fine Short Pen Needle | 22 | $2,179 | $99 |
| Amlodipine Besylate | 233 | $2,087 | $9 |
| Ventolin Hfa | 29 | $1,948 | $67 |
| Metformin | 213 | $1,840 | $9 |
| Colchicine | 18 | $1,823 | $101 |
| Baclofen | 69 | $1,693 | $25 |
| Enalapril Maleate | 54 | $1,674 | $31 |
| Diclofenac | 60 | $1,501 | $25 |
| Pregabalin | 30 | $1,388 | $46 |
| Losartan | 96 | $1,352 | $14 |
| Duloxetine | 21 | $1,326 | $63 |
| Omeprazole | 82 | $1,222 | $15 |
| Calcipotriene | 11 | $1,202 | $109 |
| Rosuvastatin | 12 | $1,153 | $96 |
| Famotidine | 46 | $992 | $22 |
| Lisinopril | 119 | $906 | $8 |
| Propranolol | 38 | $862 | $23 |
| Glipizide | 67 | $835 | $12 |
| Levothyroxine | 39 | $791 | $20 |
| Terazosin | 16 | $760 | $48 |
| Lovastatin | 63 | $751 | $12 |
| Finasteride | 37 | $750 | $20 |
| Sertraline | 44 | $722 | $16 |
| Hydralazine | 14 | $721 | $52 |
| Chlorthalidone | 21 | $694 | $33 |
| Metoprolol | 28 | $685 | $24 |
| Fluticasone Propionate | 43 | $683 | $16 |
| Nortriptyline | 14 | $670 | $48 |
| Simvastatin | 84 | $656 | $8 |
| Montelukast | 13 | $634 | $49 |
| Carvedilol | 37 | $632 | $17 |
| Halobetasol Propionate | 11 | $629 | $57 |
| Metolazone | 12 | $611 | $51 |
| Betamethasone Dipropionate | 12 | $597 | $50 |
| Oxycodone | 23 | $596 | $26 |
| Pantoprazole | 33 | $582 | $18 |
| Sucralfate | 15 | $538 | $36 |
| Alendronate | 46 | $532 | $12 |
| Trazodone | 60 | $515 | $9 |
| Allopurinol | 28 | $504 | $18 |
| Olanzapine | 21 | $440 | $21 |
| Prednisone | 23 | $407 | $18 |
| Quetiapine | 28 | $386 | $14 |
| Isosorbide Mononitrate Er | 24 | $368 | $15 |
| Hydroxyzine | 18 | $367 | $20 |
| Ezetimibe | 15 | $367 | $24 |
| Mirtazapine | 21 | $364 | $17 |
| Furosemide | 43 | $360 | $8 |
| Losartan-Hydrochlorothiazide | 17 | $342 | $20 |
| Levetiracetam | 11 | $332 | $30 |
| Clotrimazole | 15 | $305 | $20 |
| Lisinopril-Hydrochlorothiazide | 34 | $284 | $8 |
| Metoprolol | 41 | $281 | $7 |
| Clonidine | 30 | $275 | $9 |
| Ondansetron Odt | 12 | $274 | $23 |
| Hydrochlorothiazide | 46 | $259 | $6 |
| Warfarin | 11 | $258 | $23 |
| Buspirone | 18 | $249 | $14 |
| Ibuprofen | 37 | $242 | $7 |
| Oxycodone-Acetaminophen | 14 | $187 | $13 |
| Naproxen | 21 | $170 | $8 |
| Meclizine | 27 | $164 | $6 |
| Clopidogrel | 13 | $157 | $12 |
| Triamcinolone Acetonide | 19 | $128 | $7 |
| Fluoxetine | 12 | $114 | $9 |
| Amoxicillin-Clavulanate Potass | 11 | $96 | $9 |
| Tramadol | 24 | $86 | $4 |
| Lamotrigine | 12 | $81 | $7 |
2020: 78 drugs
| Novolog Flexpen | 60 | $31,064 | $518 |
| Eliquis | 45 | $26,237 | $583 |
| Basaglar Kwikpen U-100 | 75 | $19,216 | $256 |
| Lantus | 24 | $14,762 | $615 |
| Symbicort | 19 | $13,817 | $727 |
| Jardiance | 22 | $12,145 | $552 |
| Flovent Hfa | 28 | $11,974 | $428 |
| Ozempic | 12 | $11,867 | $989 |
| Lantus Solostar | 15 | $10,940 | $729 |
| Tradjenta | 12 | $10,258 | $855 |
| Advair Diskus | 19 | $9,873 | $520 |
| Spiriva Respimat | 17 | $8,058 | $474 |
| Pradaxa | 14 | $6,625 | $473 |
| Suboxone | 12 | $5,337 | $445 |
| Carbamazepine Er | 20 | $5,244 | $262 |
| Gabapentin | 130 | $3,938 | $30 |
| Ventolin Hfa | 55 | $3,670 | $67 |
| Buprenorphine-Naloxone | 13 | $3,091 | $238 |
| Atorvastatin | 233 | $3,064 | $13 |
| Hydrocodone-Acetaminophen | 69 | $2,489 | $36 |
| Ultra-Fine Short Pen Needle | 24 | $2,480 | $103 |
| Tamsulosin | 99 | $2,305 | $23 |
| Albuterol Sulfate Hfa | 50 | $2,184 | $44 |
| Enalapril Maleate | 52 | $1,804 | $35 |
| Ondansetron Odt | 12 | $1,576 | $131 |
| Metformin | 182 | $1,548 | $9 |
| Levothyroxine | 55 | $1,281 | $23 |
| Nifedipine Er | 19 | $1,275 | $67 |
| Amlodipine Besylate | 218 | $1,260 | $6 |
| Baclofen | 43 | $1,180 | $27 |
| Losartan | 91 | $1,052 | $12 |
| Chlorthalidone | 30 | $1,004 | $33 |
| Omeprazole | 93 | $922 | $10 |
| Sertraline | 58 | $891 | $15 |
| Lisinopril | 117 | $824 | $7 |
| Lovastatin | 56 | $755 | $13 |
| Fluticasone Propionate | 44 | $711 | $16 |
| Nortriptyline | 15 | $670 | $45 |
| Famotidine | 40 | $624 | $16 |
| Pregabalin | 12 | $611 | $51 |
| Simvastatin | 70 | $588 | $8 |
| Oxycodone | 21 | $580 | $28 |
| Glipizide | 67 | $575 | $9 |
| Finasteride | 31 | $532 | $17 |
| Metoprolol | 27 | $490 | $18 |
| Alendronate | 54 | $429 | $8 |
| Fluoxetine | 13 | $406 | $31 |
| Hydroxyzine | 23 | $385 | $17 |
| Allopurinol | 21 | $381 | $18 |
| Clotrimazole | 30 | $368 | $12 |
| Isosorbide Mononitrate Er | 17 | $360 | $21 |
| Olanzapine | 22 | $358 | $16 |
| Trazodone | 31 | $341 | $11 |
| Ondansetron | 11 | $341 | $31 |
| Diclofenac | 13 | $341 | $26 |
| Pantoprazole | 31 | $339 | $11 |
| Cyclobenzaprine | 17 | $331 | $19 |
| Carvedilol | 34 | $310 | $9 |
| Pioglitazone | 12 | $272 | $23 |
| Propranolol | 12 | $258 | $22 |
| Terazosin | 11 | $242 | $22 |
| Escitalopram | 17 | $193 | $11 |
| Ibuprofen | 35 | $189 | $5 |
| Lisinopril-Hydrochlorothiazide | 27 | $180 | $7 |
| Quetiapine | 17 | $174 | $10 |
| Montelukast | 13 | $168 | $13 |
| Metoprolol | 35 | $150 | $4 |
| Clonidine | 15 | $149 | $10 |
| Furosemide | 34 | $148 | $4 |
| Prednisone | 13 | $146 | $11 |
| Ketoconazole | 12 | $146 | $12 |
| Meclizine | 21 | $140 | $7 |
| Hydrochlorothiazide | 34 | $134 | $4 |
| Tramadol | 25 | $131 | $5 |
| Triamcinolone Acetonide | 17 | $117 | $7 |
| Zolpidem | 11 | $94 | $9 |
| Bupropion Hcl Sr | 12 | $86 | $7 |
| Lamotrigine | 11 | $75 | $7 |
2019: 72 drugs
| Novolog Flexpen | 90 | $42,431 | $471 |
| Basaglar Kwikpen U-100 | 89 | $23,275 | $262 |
| Lantus Solostar | 28 | $17,416 | $622 |
| Flovent Hfa | 42 | $16,129 | $384 |
| Eliquis | 33 | $14,845 | $450 |
| Vemlidy | 12 | $14,025 | $1,169 |
| Spiriva | 18 | $13,463 | $748 |
| Pradaxa | 20 | $10,833 | $542 |
| Lantus | 19 | $10,728 | $565 |
| Symbicort | 12 | $9,588 | $799 |
| Incruse Ellipta | 16 | $8,086 | $505 |
| Buprenorphine-Naloxone | 20 | $7,139 | $357 |
| Ventolin Hfa | 63 | $4,062 | $64 |
| Atorvastatin | 220 | $3,811 | $17 |
| Gabapentin | 92 | $2,986 | $32 |
| Enalapril Maleate | 45 | $2,348 | $52 |
| Ultra-Fine Short Pen Needle | 28 | $2,187 | $78 |
| Tamsulosin | 76 | $1,893 | $25 |
| Potassium Chloride | 11 | $1,700 | $155 |
| Amlodipine Besylate | 204 | $1,553 | $8 |
| Omeprazole | 114 | $1,421 | $12 |
| Metformin | 168 | $1,385 | $8 |
| Levothyroxine | 53 | $1,250 | $24 |
| Fluticasone Propionate | 84 | $1,128 | $13 |
| Losartan | 86 | $1,083 | $13 |
| Metoprolol | 27 | $1,034 | $38 |
| Nifedipine Er | 22 | $946 | $43 |
| Methotrexate | 12 | $878 | $73 |
| Lisinopril | 98 | $873 | $9 |
| Lovastatin | 73 | $847 | $12 |
| Ranitidine | 44 | $833 | $19 |
| Finasteride | 27 | $808 | $30 |
| Fluoxetine | 14 | $807 | $58 |
| Duloxetine | 16 | $798 | $50 |
| Nystop | 19 | $797 | $42 |
| Clotrimazole | 32 | $794 | $25 |
| Simvastatin | 77 | $741 | $10 |
| Hydrocodone-Acetaminophen | 32 | $738 | $23 |
| Albuterol Sulfate Hfa | 15 | $701 | $47 |
| Hydralazine | 19 | $678 | $36 |
| Alendronate | 56 | $662 | $12 |
| Glipizide | 60 | $658 | $11 |
| Terazosin | 23 | $634 | $28 |
| Oxycodone | 14 | $619 | $44 |
| Chlorthalidone | 15 | $616 | $41 |
| Flunisolide | 11 | $598 | $54 |
| Baclofen | 33 | $593 | $18 |
| Allopurinol | 28 | $576 | $21 |
| Famotidine | 31 | $534 | $17 |
| Nortriptyline | 11 | $524 | $48 |
| Sertraline | 33 | $507 | $15 |
| Isosorbide Mononitrate Er | 27 | $476 | $18 |
| Lisinopril-Hydrochlorothiazide | 44 | $414 | $9 |
| Warfarin | 15 | $385 | $26 |
| Montelukast | 12 | $361 | $30 |
| Trazodone | 17 | $349 | $21 |
| Triamcinolone Acetonide | 28 | $324 | $12 |
| Ibuprofen | 37 | $273 | $7 |
| Metoprolol | 29 | $256 | $9 |
| Carvedilol | 24 | $246 | $10 |
| Losartan-Hydrochlorothiazide | 34 | $234 | $7 |
| Triamterene-Hydrochlorothiazid | 12 | $230 | $19 |
| Furosemide | 30 | $192 | $6 |
| Olanzapine | 12 | $190 | $16 |
| Prednisone | 20 | $162 | $8 |
| Hydrochlorothiazide | 27 | $155 | $6 |
| Escitalopram | 11 | $154 | $14 |
| Meclizine | 17 | $128 | $8 |
| Zolpidem | 17 | $112 | $7 |
| Cromolyn | 11 | $107 | $10 |
| Pantoprazole | 11 | $97 | $9 |
| Meloxicam | 18 | $70 | $4 |
2018: 73 drugs
| Lantus Solostar | 36 | $20,300 | $564 |
| Novolog Flexpen | 36 | $19,750 | $549 |
| Basaglar Kwikpen U-100 | 55 | $16,541 | $301 |
| Vemlidy | 13 | $14,656 | $1,127 |
| Lantus | 28 | $13,041 | $466 |
| Pradaxa | 23 | $12,858 | $559 |
| Flovent Hfa | 31 | $12,538 | $404 |
| Spiriva | 18 | $12,216 | $679 |
| Entecavir | 12 | $10,156 | $846 |
| Novolog | 18 | $8,870 | $493 |
| Symbicort | 18 | $7,907 | $439 |
| Eliquis | 18 | $7,633 | $424 |
| Ventolin Hfa | 107 | $5,901 | $55 |
| Suboxone | 12 | $4,573 | $381 |
| Incruse Ellipta | 12 | $3,936 | $328 |
| Atorvastatin | 207 | $3,858 | $19 |
| Ultra-Fine Short Pen Needle | 37 | $2,368 | $64 |
| Enalapril Maleate | 44 | $2,223 | $51 |
| Gabapentin | 95 | $2,199 | $23 |
| Tamsulosin | 63 | $2,039 | $32 |
| Hydrocodone-Acetaminophen | 38 | $1,341 | $35 |
| Amlodipine Besylate | 186 | $1,257 | $7 |
| Levothyroxine | 56 | $1,238 | $22 |
| Metformin | 148 | $1,144 | $8 |
| Fluticasone Propionate | 76 | $901 | $12 |
| Omeprazole | 73 | $891 | $12 |
| Nifedipine Er | 18 | $867 | $48 |
| Lovastatin | 82 | $855 | $10 |
| Baclofen | 47 | $817 | $17 |
| Lisinopril | 108 | $806 | $7 |
| Chlorthalidone | 12 | $758 | $63 |
| Glipizide | 60 | $753 | $13 |
| Ranitidine | 51 | $743 | $15 |
| Finasteride | 27 | $713 | $26 |
| Losartan | 67 | $700 | $10 |
| Clotrimazole | 30 | $689 | $23 |
| Duloxetine | 19 | $656 | $35 |
| Flunisolide | 12 | $652 | $54 |
| Oxycodone | 12 | $604 | $50 |
| Metoprolol | 17 | $601 | $35 |
| Allopurinol | 30 | $567 | $19 |
| Simvastatin | 68 | $567 | $8 |
| Alendronate | 43 | $535 | $12 |
| Valsartan | 22 | $516 | $23 |
| Hydralazine | 26 | $487 | $19 |
| Sertraline | 37 | $439 | $12 |
| Nortriptyline | 12 | $393 | $33 |
| Isosorbide Mononitrate Er | 25 | $378 | $15 |
| Terazosin | 19 | $375 | $20 |
| Warfarin | 19 | $349 | $18 |
| Insulin | 13 | $337 | $26 |
| Metoprolol | 33 | $317 | $10 |
| Triamterene-Hydrochlorothiazid | 15 | $304 | $20 |
| Triamcinolone Acetonide | 27 | $299 | $11 |
| Famotidine | 27 | $290 | $11 |
| Trazodone | 26 | $279 | $11 |
| Hydrochlorothiazide | 41 | $250 | $6 |
| Ibuprofen | 32 | $250 | $8 |
| Nystop | 15 | $216 | $14 |
| Clonidine | 14 | $209 | $15 |
| Fluoxetine | 11 | $202 | $18 |
| Montelukast | 12 | $196 | $16 |
| Furosemide | 32 | $191 | $6 |
| Pantoprazole | 17 | $185 | $11 |
| Olanzapine | 13 | $182 | $14 |
| Latanoprost | 14 | $168 | $12 |
| Lisinopril-Hydrochlorothiazide | 28 | $161 | $6 |
| Carvedilol | 24 | $135 | $6 |
| Losartan-Hydrochlorothiazide | 11 | $84 | $8 |
| Prednisone | 14 | $75 | $5 |
| Escitalopram | 13 | $70 | $5 |
| Cromolyn | 12 | $65 | $5 |
| Citalopram Hbr | 12 | $61 | $5 |
2017: 78 drugs
| Lantus | 78 | $28,563 | $366 |
| Novolog | 32 | $13,793 | $431 |
| Entecavir | 12 | $10,116 | $843 |
| Pradaxa | 22 | $9,659 | $439 |
| Lantus Solostar | 22 | $9,634 | $438 |
| Flovent Hfa | 31 | $9,516 | $307 |
| Spiriva | 14 | $8,058 | $576 |
| Atrovent Hfa | 19 | $8,040 | $423 |
| Novolin N | 12 | $5,195 | $433 |
| Ventolin Hfa | 89 | $4,762 | $54 |
| Anoro Ellipta | 11 | $3,965 | $360 |
| Symbicort | 11 | $3,915 | $356 |
| Incruse Ellipta | 11 | $3,637 | $331 |
| Atorvastatin | 144 | $2,833 | $20 |
| Enalapril Maleate | 47 | $2,293 | $49 |
| Gabapentin | 107 | $1,866 | $17 |
| Tamsulosin | 49 | $1,690 | $34 |
| Isosorbide Dinitrate | 15 | $1,345 | $90 |
| Amlodipine Besylate | 151 | $1,227 | $8 |
| Levothyroxine | 47 | $1,217 | $26 |
| Olanzapine | 13 | $1,082 | $83 |
| Proair Hfa | 18 | $1,043 | $58 |
| Fluticasone Propionate | 85 | $1,004 | $12 |
| Metformin | 130 | $875 | $7 |
| Valsartan | 34 | $804 | $24 |
| Losartan | 75 | $795 | $11 |
| Omeprazole | 89 | $769 | $9 |
| Lovastatin | 90 | $765 | $8 |
| Baclofen | 61 | $762 | $12 |
| Allopurinol | 35 | $717 | $20 |
| Finasteride | 25 | $687 | $27 |
| Chlorthalidone | 19 | $675 | $36 |
| Hydralazine | 35 | $661 | $19 |
| Duloxetine | 18 | $659 | $37 |
| Hydrocodone-Acetaminophen | 41 | $644 | $16 |
| Flunisolide | 12 | $629 | $52 |
| Warfarin | 32 | $576 | $18 |
| Lisinopril | 93 | $558 | $6 |
| Nifedipine Er | 12 | $527 | $44 |
| Simvastatin | 64 | $516 | $8 |
| Clotrimazole | 20 | $476 | $24 |
| Metoprolol | 11 | $473 | $43 |
| Insulin | 19 | $468 | $25 |
| Glipizide | 42 | $466 | $11 |
| Bupropion Hcl Sr | 14 | $438 | $31 |
| Fluoxetine | 12 | $427 | $36 |
| Insulin | 18 | $398 | $22 |
| Metoprolol | 46 | $346 | $8 |
| Terazosin | 23 | $324 | $14 |
| Montelukast | 13 | $299 | $23 |
| Latanoprost | 15 | $296 | $20 |
| Sertraline | 34 | $295 | $9 |
| Ranitidine | 21 | $268 | $13 |
| Alendronate | 28 | $265 | $9 |
| Triamterene-Hydrochlorothiazid | 13 | $259 | $20 |
| Mirtazapine | 11 | $253 | $23 |
| Probenecid-Colchicine | 11 | $229 | $21 |
| Famotidine | 33 | $227 | $7 |
| Prednisone | 26 | $225 | $9 |
| Donepezil | 14 | $224 | $16 |
| Quetiapine | 12 | $193 | $16 |
| Hydrochlorothiazide | 39 | $179 | $5 |
| Furosemide | 39 | $177 | $5 |
| Clonidine | 16 | $169 | $11 |
| Pantoprazole | 14 | $145 | $10 |
| Trazodone | 18 | $143 | $8 |
| Escitalopram | 11 | $135 | $12 |
| Torsemide | 11 | $135 | $12 |
| Hydrocortisone | 18 | $121 | $7 |
| Triamcinolone Acetonide | 21 | $118 | $6 |
| Tramadol | 19 | $100 | $5 |
| Ondansetron | 12 | $98 | $8 |
| Isosorbide Mononitrate Er | 13 | $96 | $7 |
| Meclizine | 14 | $91 | $7 |
| Lisinopril-Hydrochlorothiazide | 15 | $89 | $6 |
| Ibuprofen | 24 | $74 | $3 |
| Cromolyn | 12 | $74 | $6 |
| Carvedilol | 15 | $74 | $5 |
2016: 58 drugs
| Lantus | 37 | $12,841 | $347 |
| Novolog | 17 | $7,798 | $459 |
| Humalog | 20 | $7,751 | $388 |
| Atrovent Hfa | 14 | $4,276 | $305 |
| Ventolin Hfa | 64 | $3,353 | $52 |
| Novolin N | 11 | $3,083 | $280 |
| Qvar | 12 | $2,428 | $202 |
| Enalapril Maleate | 43 | $1,778 | $41 |
| Omega-3 Acid Ethyl Esters | 11 | $1,692 | $154 |
| Gabapentin | 92 | $1,667 | $18 |
| Proair Hfa | 29 | $1,593 | $55 |
| Atorvastatin | 94 | $1,538 | $16 |
| Econazole Nitrate | 21 | $1,327 | $63 |
| Hydrocodone-Acetaminophen | 34 | $1,241 | $37 |
| Valsartan | 33 | $999 | $30 |
| Warfarin | 37 | $995 | $27 |
| Tamsulosin | 30 | $866 | $29 |
| Amlodipine Besylate | 117 | $767 | $7 |
| Metformin | 117 | $738 | $6 |
| Hydralazine | 29 | $722 | $25 |
| Allopurinol | 32 | $714 | $22 |
| Levothyroxine | 25 | $711 | $28 |
| Clotrimazole | 27 | $657 | $24 |
| Finasteride | 29 | $635 | $22 |
| Omeprazole | 74 | $582 | $8 |
| Lovastatin | 67 | $568 | $8 |
| Oxycodone-Acetaminophen | 12 | $557 | $46 |
| Morphine Sulfate Er | 13 | $552 | $42 |
| Baclofen | 34 | $529 | $16 |
| Chlorthalidone | 14 | $494 | $35 |
| Losartan | 72 | $482 | $7 |
| Fluticasone Propionate | 55 | $452 | $8 |
| Mirtazapine | 19 | $429 | $23 |
| Pravastatin | 13 | $365 | $28 |
| Metoprolol | 13 | $315 | $24 |
| Terazosin | 19 | $312 | $16 |
| Glipizide | 29 | $309 | $11 |
| Simvastatin | 58 | $290 | $5 |
| Acyclovir | 16 | $290 | $18 |
| Lisinopril | 60 | $290 | $5 |
| Ranitidine | 18 | $259 | $14 |
| Probenecid-Colchicine | 11 | $245 | $22 |
| Clonidine | 13 | $208 | $16 |
| Donepezil | 12 | $203 | $17 |
| Famotidine | 21 | $195 | $9 |
| Triamterene-Hydrochlorothiazid | 11 | $188 | $17 |
| Ibuprofen | 28 | $183 | $7 |
| Hydrochlorothiazide | 41 | $182 | $4 |
| Metoprolol | 34 | $162 | $5 |
| Alendronate | 14 | $160 | $11 |
| Trazodone | 17 | $160 | $9 |
| Sertraline | 18 | $119 | $7 |
| Acetaminophen-Codeine | 13 | $119 | $9 |
| Prednisone | 14 | $113 | $8 |
| Isosorbide Mononitrate Er | 13 | $110 | $8 |
| Carvedilol | 15 | $106 | $7 |
| Lamotrigine | 11 | $102 | $9 |
| Furosemide | 13 | $92 | $7 |
2015: 32 drugs
| Lantus | 11 | $9,100 | $827 |
| Atrovent Hfa | 12 | $4,260 | $355 |
| Morphine Sulfate Er | 18 | $2,061 | $114 |
| Qvar | 12 | $1,801 | $150 |
| Clotrimazole | 16 | $1,140 | $71 |
| Proair Hfa | 21 | $1,068 | $51 |
| Valsartan | 19 | $865 | $46 |
| Gabapentin | 35 | $796 | $23 |
| Enalapril Maleate | 19 | $768 | $40 |
| Levothyroxine | 25 | $619 | $25 |
| Finasteride | 24 | $603 | $25 |
| Hydrocodone-Acetaminophen | 25 | $595 | $24 |
| Oxycodone-Acetaminophen | 12 | $534 | $44 |
| Atorvastatin | 30 | $492 | $16 |
| Warfarin | 24 | $469 | $20 |
| Pravastatin | 11 | $450 | $41 |
| Tamsulosin | 13 | $399 | $31 |
| Fluticasone Propionate | 37 | $361 | $10 |
| Amlodipine Besylate | 50 | $316 | $6 |
| Lovastatin | 26 | $304 | $12 |
| Omeprazole | 35 | $285 | $8 |
| Triamterene-Hydrochlorothiazid | 16 | $285 | $18 |
| Lisinopril | 41 | $271 | $7 |
| Ibuprofen | 33 | $259 | $8 |
| Metformin | 34 | $258 | $8 |
| Glipizide | 16 | $255 | $16 |
| Baclofen | 18 | $212 | $12 |
| Simvastatin | 17 | $184 | $11 |
| Losartan | 23 | $142 | $6 |
| Metoprolol | 25 | $91 | $4 |
| Hydrochlorothiazide | 22 | $85 | $4 |
| Atenolol | 18 | $81 | $5 |
2014: 4 drugs
| Lisinopril | 20 | $173 | $9 |
| Omeprazole | 14 | $161 | $11 |
| Metformin | 17 | $128 | $8 |
| Ibuprofen | 16 | $91 | $6 |
Money from drug and device companies
$49 in 2025
A payment is not proof that care is biased.
| Pfizer | Elrexfio | $49 | 1 payment
|
See the published payment
| Pfizer | Meals · 2025-04-12 | Elrexfio | $49 |
Professional record
- NPI
- 1760744874
- Licence
- CA A 121497California A121497: Current · expires 2027-11-30
- Trained
- University of Missouri, Columbia School of Medicine, 2010 · 16 years ago
- Group
- La Clinica De La Raza Inc · Permanente Medical Group Inc
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 1030 International Blvd, Oakland, CA, 94606
- NPI first listed
- 2012-06-14
- NPI last updated
- 2022-02-11
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.